Masimo Debt to Equity Ratio 2007-2019 | MASI

Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending March 31, 2019 was 0.00.
Masimo Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-03-31 $0.00B $1.01B 0.00
2018-12-31 $0.00B $0.97B 0.00
2018-09-30 $0.00B $0.91B 0.00
2018-06-30 $0.00B $0.83B 0.00
2018-03-31 $0.00B $0.77B 0.00
2017-12-31 $0.00B $0.72B 0.00
2017-09-30 $0.00B $0.72B 0.00
2017-06-30 $0.00B $0.71B 0.00
2017-03-31 $0.00B $0.63B 0.00
2016-12-31 $0.00B $0.56B 0.00
2016-09-30 $0.15B $0.33B 0.46
2016-06-30 $0.18B $0.30B 0.59
2016-03-31 $0.23B $0.27B 0.84
2015-12-31 $0.19B $0.28B 0.67
2015-09-30 $0.19B $0.27B 0.71
2015-06-30 $0.18B $0.28B 0.63
2015-03-31 $0.13B $0.33B 0.39
2014-12-31 $0.13B $0.31B 0.41
2014-09-30 $0.00B $0.28B 0.00
2014-06-30 $0.00B $0.32B 0.00
2014-03-31 $0.00B $0.35B 0.00
2013-12-31 $0.00B $0.33B 0.00
2013-09-30 $0.00B $0.31B 0.00
2013-06-30 $0.00B $0.29B 0.00
2013-03-31 $0.00B $0.28B 0.00
2012-12-31 $0.00B $0.28B 0.00
2012-09-30 $0.00B $0.31B 0.00
2012-06-30 $0.00B $0.30B 0.00
2012-03-31 $0.00B $0.28B 0.00
2011-12-31 $0.00B $0.28B 0.00
2011-09-30 $0.00B $0.30B 0.00
2011-06-30 $0.00B $0.28B 0.00
2011-03-31 $0.00B $0.26B 0.00
2010-12-31 $0.00B $0.23B 0.00
2010-09-30 $0.00B $0.25B 0.00
2010-06-30 $0.00B $0.23B 0.00
2010-03-31 $0.00B $0.21B 0.00
2009-12-31 $0.00B $0.29B 0.00
2009-09-30 $0.00B $0.27B 0.00
2009-06-30 $0.00B $0.25B 0.00
2009-03-31 $0.00B $0.24B 0.00
2008-12-31 $0.00B $0.22B 0.00
2008-09-30 $0.00B $0.21B 0.00
2008-06-30 $0.00B $0.19B 0.00
2008-03-31 $0.00B $0.17B 0.00
2007-12-31 $0.02B $0.15B 0.13
2007-09-30 $0.02B $0.14B 0.16
2007-06-30 $0.03B $-0.02B -1.67
2007-03-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.717B $0.858B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $118.214B 25.86
Intuitive Surgical (ISRG) United States $60.703B 55.94
Edwards Lifesciences (EW) United States $39.982B 39.95
Fresenius Medical Care AG KGaA (FMS) Germany $23.873B 15.69
IDEXX Laboratories (IDXX) United States $23.663B 62.08
Teleflex (TFX) United States $15.360B 33.28
DexCom (DXCM) United States $13.445B 263.68
Hologic (HOLX) United States $13.006B 20.91
Varian Medical Systems (VAR) United States $12.387B 31.60
STERIS (STE) Ireland $12.285B 29.71
ABIOMED (ABMD) United States $11.424B 69.74
Penumbra (PEN) United States $5.717B 242.04
Integra LifeSciences Holdings (IART) United States $4.551B 21.38
Globus Medical (GMED) United States $4.213B 26.27
Wright Medical Group (WMGI) Netherlands $3.776B 748.50
Tandem Diabetes Care (TNDM) United States $3.719B 0.00
LivaNova (LIVN) United Kingdom $3.638B 23.71
Cantel Medical (CMD) United States $3.149B 31.95
Integer Holdings (ITGR) United States $2.716B 20.01
Glaukos (GKOS) United States $2.674B 0.00
AVANOS MEDICAL, INC (AVNS) United States $2.003B 31.71
Nevro (NVRO) United States $1.955B 0.00
ShockWave Medical (SWAV) United States $1.608B 0.00
Inogen (INGN) United States $1.561B 34.56
Silk Road Medical (SILK) United States $1.446B 0.00
OPKO Health (OPK) United States $1.250B 0.00
Veracyte (VCYT) United States $1.135B 0.00
CryoLife (CRY) United States $1.116B 110.67
Accelerate Diagnostics (AXDX) United States $1.103B 0.00
Tactile Systems Technology (TCMD) United States $1.024B 151.14
ORTHOFIX MEDICAL INC (OFIX) United States $1.002B 29.02
Pacific Biosciences Of California (PACB) United States $0.925B 0.00
Luminex (LMNX) United States $0.920B 120.29
Mesa Laboratories (MLAB) United States $0.882B 41.49
Fluidigm (FLDM) United States $0.845B 0.00
ViewRay (VRAY) United States $0.835B 0.00
Natus Medical (BABY) United States $0.831B 19.24
AxoGen (AXGN) United States $0.757B 0.00
AngioDynamics (ANGO) United States $0.721B 25.14
Intersect ENT (XENT) United States $0.718B 0.00
Corindus Vascular Robotics (CVRS) United States $0.664B 0.00
Quotient (QTNT) Switzerland $0.617B 0.00
OrthoPediatrics (KIDS) United States $0.580B 0.00
Si-Bone (SIBN) United States $0.435B 0.00
GenMark Diagnostics (GNMK) United States $0.367B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.365B 19.57
Accuray (ARAY) United States $0.340B 0.00
RTI Surgical (RTIX) United States $0.322B 39.64
TransEnterix (TRXC) United States $0.265B 0.00
ConforMIS (CFMS) United States $0.263B 0.00
SeaSpine Holdings (SPNE) United States $0.262B 0.00
Pulse Biosciences (PLSE) United States $0.249B 0.00
IRadimed (IRMD) United States $0.237B 45.28
Neuronetics (STIM) United States $0.229B 0.00
Soliton (SOLY) United States $0.223B 0.00
CRH Medical (CRHM) Canada $0.209B 73.25
Alphatec Holdings (ATEC) United States $0.198B 0.00
Sientra (SIEN) United States $0.190B 0.00
Biosig Technologies (BSGM) United States $0.189B 0.00
Second Sight Medical Products (EYES) United States $0.099B 0.00
Ekso Bionics Holdings (EKSO) United States $0.096B 0.00
Sensus Healthcare (SRTS) United States $0.084B 0.00
Apollo Endosurgery (APEN) United States $0.080B 0.00
T2 Biosystems (TTOO) United States $0.078B 0.00
EDAP TMS (EDAP) France $0.077B 0.00
Vermillion (VRML) United States $0.076B 0.00
Nuvectra (NVTR) United States $0.061B 0.00
Helius Medical Technologies (HSDT) United States $0.060B 0.00
Titan Medical (TMDI) Canada $0.050B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.050B 0.00
Electromed (ELMD) United States $0.044B 22.83
Ra Medical Systems (RMED) United States $0.044B 0.00
Neovasc (NVCN) Canada $0.042B 0.00
Xtant Medical Holdings (XTNT) United States $0.037B 0.00
PAVmed (PAVM) United States $0.036B 0.00
Avinger (AVGR) United States $0.024B 0.00
OBALON THERPTCS (OBLN) United States $0.023B 0.00
Lianluo Smart (LLIT) China $0.023B 0.00
Microbot Medical (MBOT) United States $0.022B 0.00
Bioanalytical Systems (BASI) United States $0.020B 0.00
Restoration Robotics (HAIR) United States $0.020B 0.00
ReWalk Robotics (RWLK) Israel $0.019B 0.00
DarioHealth (DRIO) Israel $0.019B 0.00
Atossa Genetics (ATOS) United States $0.019B 0.00
Viveve Medical (VIVE) United States $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.017B 18.38
Dynatronics (DYNT) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.007B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
ALCON INC (ALC) $0.000B 0.00